Alterity Therapeutics Stock (NASDAQ: ATHE) stock price, news, charts, stock research, profile.
You can purchase shares of Alterity Therapeutics (NASDAQ:ATHE) through any online brokerage.
Other companies in Alterity Therapeutics’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Vincerx Pharma (NASDAQ:VINC), NKGen Biotech (NASDAQ:NKGN), Galecto (NASDAQ:GLTO) and Immuron (NASDAQ:IMRN).
Alterity Therapeutics has a consensus price target of $5.67.
The stock price for Alterity Therapeutics (NASDAQ: ATHE) is $1.2 last updated October 31, 2024 at 8:16 AM EDT.
There are no upcoming dividends for Alterity Therapeutics.
Alterity Therapeutics’s Q2 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Alterity Therapeutics.
Alterity Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.